Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and-18 Infections
Mikolajczyk RT, Horn J, Damm O, Kaufmann AM, Kretzschmar MEE (2012)
JNCI Journal of the National Cancer Institute 104(2): 163.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Mikolajczyk, Rafael T.;
Horn, Johannes;
Damm, OliverUniBi;
Kaufmann, Andreas M.;
Kretzschmar, Mirjam E. E.
Einrichtung
Erscheinungsjahr
2012
Zeitschriftentitel
JNCI Journal of the National Cancer Institute
Band
104
Ausgabe
2
Seite(n)
163
ISSN
0027-8874
eISSN
1460-2105
Page URI
https://pub.uni-bielefeld.de/record/2474515
Zitieren
Mikolajczyk RT, Horn J, Damm O, Kaufmann AM, Kretzschmar MEE. Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and-18 Infections. JNCI Journal of the National Cancer Institute. 2012;104(2):163.
Mikolajczyk, R. T., Horn, J., Damm, O., Kaufmann, A. M., & Kretzschmar, M. E. E. (2012). Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and-18 Infections. JNCI Journal of the National Cancer Institute, 104(2), 163. doi:10.1093/jnci/djr517
Mikolajczyk, Rafael T., Horn, Johannes, Damm, Oliver, Kaufmann, Andreas M., and Kretzschmar, Mirjam E. E. 2012. “Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and-18 Infections”. JNCI Journal of the National Cancer Institute 104 (2): 163.
Mikolajczyk, R. T., Horn, J., Damm, O., Kaufmann, A. M., and Kretzschmar, M. E. E. (2012). Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and-18 Infections. JNCI Journal of the National Cancer Institute 104, 163.
Mikolajczyk, R.T., et al., 2012. Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and-18 Infections. JNCI Journal of the National Cancer Institute, 104(2), p 163.
R.T. Mikolajczyk, et al., “Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and-18 Infections”, JNCI Journal of the National Cancer Institute, vol. 104, 2012, pp. 163.
Mikolajczyk, R.T., Horn, J., Damm, O., Kaufmann, A.M., Kretzschmar, M.E.E.: Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and-18 Infections. JNCI Journal of the National Cancer Institute. 104, 163 (2012).
Mikolajczyk, Rafael T., Horn, Johannes, Damm, Oliver, Kaufmann, Andreas M., and Kretzschmar, Mirjam E. E. “Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and-18 Infections”. JNCI Journal of the National Cancer Institute 104.2 (2012): 163.
Daten bereitgestellt von European Bioinformatics Institute (EBI)
2 Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
Cost-effectiveness of human papillomavirus vaccination in Germany.
Damm O, Horn J, Mikolajczyk RT, Kretzschmar MEE, Kaufmann AM, Deleré Y, Ultsch B, Wichmann O, Krämer A, Greiner W., Cost Eff Resour Alloc 15(), 2017
PMID: 28878573
Damm O, Horn J, Mikolajczyk RT, Kretzschmar MEE, Kaufmann AM, Deleré Y, Ultsch B, Wichmann O, Krämer A, Greiner W., Cost Eff Resour Alloc 15(), 2017
PMID: 28878573
The role of acquired immunity in the spread of human papillomavirus (HPV): explorations with a microsimulation model.
Matthijsse SM, van Rosmalen J, Hontelez JA, Bakker R, de Kok IM, van Ballegooijen M, de Vlas SJ., PLoS One 10(2), 2015
PMID: 25642941
Matthijsse SM, van Rosmalen J, Hontelez JA, Bakker R, de Kok IM, van Ballegooijen M, de Vlas SJ., PLoS One 10(2), 2015
PMID: 25642941
5 References
Daten bereitgestellt von Europe PubMed Central.
Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections.
Safaeian M, Porras C, Schiffman M, Rodriguez AC, Wacholder S, Gonzalez P, Quint W, van Doorn LJ, Sherman ME, Xhenseval V, Herrero R, Hildesheim A; Costa Rican Vaccine Trial Group, Alfaro M, Barrantes M, Bratti MC, Cardenas F, Cortes B, Espinoza A, Estrada Y, Gonzalez P, Guillen D, Herrero R, Jimenez SE, Morales J, Morera LA, Perez E, Porras C, Rodriguez AC, Villegas M, Freer E, Bonilla J, Silva S, Atmella I, Ramirez M, Macklin N, Hildesheim A, Lowy DR, Schiffman M, Schiller JT, Sherman M, Solomon D, Wacholder S, Pinto L, Garcia-Pineres A, Eklund C, Hutchinson M, Quint W, van Doorn LJ, Bougelet C., J. Natl. Cancer Inst. 102(21), 2010
PMID: 20944077
Safaeian M, Porras C, Schiffman M, Rodriguez AC, Wacholder S, Gonzalez P, Quint W, van Doorn LJ, Sherman ME, Xhenseval V, Herrero R, Hildesheim A; Costa Rican Vaccine Trial Group, Alfaro M, Barrantes M, Bratti MC, Cardenas F, Cortes B, Espinoza A, Estrada Y, Gonzalez P, Guillen D, Herrero R, Jimenez SE, Morales J, Morera LA, Perez E, Porras C, Rodriguez AC, Villegas M, Freer E, Bonilla J, Silva S, Atmella I, Ramirez M, Macklin N, Hildesheim A, Lowy DR, Schiffman M, Schiller JT, Sherman M, Solomon D, Wacholder S, Pinto L, Garcia-Pineres A, Eklund C, Hutchinson M, Quint W, van Doorn LJ, Bougelet C., J. Natl. Cancer Inst. 102(21), 2010
PMID: 20944077
Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection.
Carter JJ, Koutsky LA, Hughes JP, Lee SK, Kuypers J, Kiviat N, Galloway DA., J. Infect. Dis. 181(6), 2000
PMID: 10837170
Carter JJ, Koutsky LA, Hughes JP, Lee SK, Kuypers J, Kiviat N, Galloway DA., J. Infect. Dis. 181(6), 2000
PMID: 10837170
Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination.
Trottier H, Mahmud S, Prado JC, Sobrinho JS, Costa MC, Rohan TE, Villa LL, Franco EL., J. Infect. Dis. 197(10), 2008
PMID: 18419547
Trottier H, Mahmud S, Prado JC, Sobrinho JS, Costa MC, Rohan TE, Villa LL, Franco EL., J. Infect. Dis. 197(10), 2008
PMID: 18419547
The natural history of type-specific human papillomavirus infections in female university students.
Richardson H, Kelsall G, Tellier P, Voyer H, Abrahamowicz M, Ferenczy A, Coutlee F, Franco EL., Cancer Epidemiol. Biomarkers Prev. 12(6), 2003
PMID: 12814991
Richardson H, Kelsall G, Tellier P, Voyer H, Abrahamowicz M, Ferenczy A, Coutlee F, Franco EL., Cancer Epidemiol. Biomarkers Prev. 12(6), 2003
PMID: 12814991
AUTHOR UNKNOWN, Vaccine 25(), 2007
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 22232131
PubMed | Europe PMC
Suchen in
Google Scholar